For: | Kobayashi T, Yokokawa H, Fujibayashi K, Haniu T, Hisaoka T, Fukuda H, Naito T. Association between high cystatin C levels and carotid atherosclerosis. World J Cardiol 2017; 9(2): 174-181 [PMID: 28289532 DOI: 10.4330/wjc.v9.i2.174] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v9/i2/174.htm |
Number | Citing Articles |
1 |
I. T. Murkamilov, K. A. Aitbaev, Z. A. Murkamilova, V. V. Fomin, Z. R. Raimzhanov, N. A. Redzhapova, F. A. Yusupov, Z. A. Aidarov. CLINICAL IMPORTANCE OF MARKERS OF RENAL DYSFUNCTION IN CARDIO-VASCULAR RISK STRATIFICATION. Eurasian heart journal 2018; (4): 64 doi: 10.38109/2225-1685-2018-4-64-78
|
2 |
Beibei Li, Jianzhong Song, Junlei Chen, Li Ma, Xinxia Li, Jiutong Li, Ming Guan. Novel Immunochromatography Assay Based on Background Fluorescence Quenching for the Sensitive Determination of Serum Cystatin C. Analytical Letters 2019; 52(8): 1340 doi: 10.1080/00032719.2018.1538232
|
3 |
Chiu-Shong Liu, Chia-Ing Li, Yuh-Cherng Guo, Chih-Hsueh Lin, Wen-Yuan Lin, Chung-Hsiang Liu, Mu-Cyun Wang, Chuan-Wei Yang, Shing-Yu Yang, Tsai-Chung Li, Cheng-Chieh Lin. Independent associations of urinary albumin-to-creatinine ratio and serum cystatin C with carotid intima-media thickness in community-living Taiwanese adults. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-02123-x
|
4 |
Maha Atef Zaki, Sahar Abd Atty, Alshaimaa M. Aboul fotouh, Nancy Samir Wahdan. Cystatin C as a predictor for carotid artery steno-occlusive disease in non-cardioembolic ischemic stroke. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2019; 55(1) doi: 10.1186/s41983-019-0096-5
|
5 |
Huihui Liu, Sifan Qian, Chongke Zhong, Aili Wang, Yanbo Peng, Hao Peng, Tan Xu, Xiaoqing Bu, Tian Xu, Deqin Geng, Yonghong Zhang. Predictive Value of Cystatin C for Stroke Recurrence in Patients With Acute Ischemic Stroke. Circulation Journal 2021; 85(2): 213 doi: 10.1253/circj.CJ-20-0771
|
6 |
Patricia Garcia-Garcia, Raquel Castejon, Pablo Tutor-Ureta, R. A. Silvestre, Susana Mellor-Pita, Carlos Jimenez-Ortiz, Miguel Yebra-Bango. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus. Clinical Rheumatology 2017; 36(12): 2709 doi: 10.1007/s10067-017-3837-9
|
7 |
Alexandr Ceasovschih, Victorita Sorodoc, Viviana Onofrei (Aursulesei), Dan Tesloianu, Cristina Tuchilus, Ecaterina Anisie, Antoniu Petris, Cristian Statescu, Elisabeta Jaba, Alexandra Stoica, Elena-Daniela Grigorescu, Irina M. Jaba, Laurentiu Sorodoc. Biomarker Utility for Peripheral Artery Disease Diagnosis in Real Clinical Practice: A Prospective Study. Diagnostics 2020; 10(9): 723 doi: 10.3390/diagnostics10090723
|
8 |
Xushuo Zhang, Sam Fishlock, Peter Sharpe, James McLaughlin. Development of Colorimetric Lateral Flow Assays with Gold Nanostructures for Cystatin C Detection. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4095103
|
9 |
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, J. A. Murkamilova, K. A. Aitbaev, Z. R. Rayimzhanov. Evaluation of nephrocerebral risk with the use of cystatin C in patients with chronic kidney disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2018; 118(9): 10 doi: 10.17116/jnevro201811809110
|
10 |
Xushuo Zhang, Sam Fishlock, Peter Sharpe, James McLaughlin. Development of colorimetric lateral flow assays with gold nanostructures for Cystatin C detection. Sensors and Actuators Reports 2022; 4: 100121 doi: 10.1016/j.snr.2022.100121
|
11 |
Qing Hao, Rebecca F. Gottesman, Ye Qiao, Li Liu, Richa Sharma, Elizabeth Selvin, Kunihiro Matsushita, Josef Coresh, Bruce A. Wasserman. Association between kidney disease measures and intracranial atherosclerosis. Neurology 2020; 94(22) doi: 10.1212/WNL.0000000000009311
|
12 |
Shangyan Liang, Qingling Li, Qianwei Lai, Ying Zhou, Hui Zhang, Xueyan Chen, Bin Yao, Wen Xu, Xubin Yang. Beta-2-Microglobulin is an Independent Risk Factor for Asymptomatic Carotid Atherosclerosis in Patients with Primary Aldosteronism. Journal of Atherosclerosis and Thrombosis 2022; 29(6): 937 doi: 10.5551/jat.62851
|
13 |
V. N. Vasilkova, I. Yu. Pchelin, T. V. Mokhort. Cystatin C as a marker of the rapid development of the atherosclerosis in patients with diabetes mellitus and chronic kidney disease. Regional blood circulation and microcirculation 2022; 21(3): 26 doi: 10.24884/1682-6655-2022-21-3-26-32
|
14 |
F I Mammadova. Effect of oxidative stress on endothelium in patients with heart failure and type 2 diabetes mellitus. Kazan medical journal 2020; 101(1): 13 doi: 10.17816/KMJ2020-13
|
15 |
Előd Ernő Nagy, Attila Puskás, Piroska Kelemen, Katalin Makó, Zoltán Brassai, Jolán Hársfalvi, Attila Frigy. Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement. Diagnostics 2022; 12(4): 833 doi: 10.3390/diagnostics12040833
|
16 |
Yungen Jiao, Yahong Qin, Zhengang Zhang, Hao Zhang, Haiwei Liu, Chen Li. Early identification of carotid vulnerable plaque in asymptomatic patients. BMC Cardiovascular Disorders 2020; 20(1) doi: 10.1186/s12872-020-01709-5
|